Overactive Bladder in Hereditary Spinocerebellar Ataxia When Antimuscarinic Therapy Has Not Achieved Continence
Urinary urgency, frequency, and incontinence are among the most common bladder storage symptoms seen in hereditary spinocerebellar ataxia. When a structured course of antimuscarinic medications does not restore continence, a next-line protocol applies — specific to patients without cognitive impairment.
Clinical scenario: Hereditary spinocerebellar ataxia with overactive bladder symptoms — urinary urgency, frequency, and incontinence — in a patient with no cognitive impairment.
Prior treatment line — goal not reached
Antimuscarinic medications were used as first-line therapy. The treatment goal — achieving continence and resolving overactive bladder symptoms — was not met. This protocol represents the structured next step after that documented failure.
Next-line approach
The structured regimen involves a procedural intervention targeting bladder control. The full selection criteria, procedural details, and clinical decision pathway are contained in the complete protocol.
References
- The most common symptoms relate to problems with storage and include urinary urgency, frequency and incontinence (overactive bladder symptoms).
- If symptoms continue to be refractory, intradetrusor injections of botulinum toxin A is likely to be an option, though it remains to be unlicensed for this indication.
- More recently, percutaneous tibial nerve stimulation has emerged as an option for managing overactive bladder symptoms.
View source ↗